• Aucun résultat trouvé

NBOG F 2010-1

N/A
N/A
Protected

Academic year: 2022

Partager "NBOG F 2010-1"

Copied!
2
0
0

Texte intégral

(1)

NBOG F 2010-1

NBOG F 2010-1 Page 1 of 2

Certificate Notification to the Commission and other Member States

IDENTIFICATION

Notification from (CA Reference)1:

Status Date (yyyy-mm-dd)2:

2017-06-09

MANUFACTURER

Manufacturer

Name:

CL Medical

Address:

4 rue Dr Pravaz

Sainte Foy Les Lyon 69110

E-mail:

France

Authorised Representative

(mandatory for manufacturers outside EEA) Name:

Address:

E-mail:

NOTIFIED BODY

Notified body number:

0086

Notified body name:

BSI

CERTIFICATE

Certificate Number:

CE 648248

Directive & Annex:

Directive 93/42/EEC Annex II excluding section 4

Scope Description:

Design, manufacture and final inspection of

meshes for treatment of male and female urinary incontinence, genito-urinary prolapse and cervical cerclage; polyester meshes for the treatment of genito-urinary prolapse by laparotomy and laparoscopy; and hernia surgical meshes.

Internationally recognised nomenclature term:

Device names, if possible3:

I-STOP: Mesh for treatment of male and female urinary incontinence, genito-urinary prolapse and cervical cerclage

Pelvi-STOP: Polyester mesh for the treatment of genito-urinary prolapse by laparotomy and laparoscopy

Parié-STOP: Hernia surgical mesh

Date of issue (yyyy-mm-dd):

2016-04-21

Expiration date (yyyy-mm-dd):

2017-09-03

STATUS COMMENT

Select 1) the Status Code that describes the change in the status of the certificate and 2) the corresponding reason code, denoted by the Status Comment.

Status Code:

Withdrawn

Status Comment4,:

03 compliance: Quality Management System failures

Reason for Decision/Comments:

Certificate cancelled due to lack of progress since

suspension on 2016-11-23. Certificate was suspensded as:

-Multiple major nonconformities were identified during the manufacturer's surveillance audit.

-Manufacturer then aborted the audit before its

(2)

NBOG F 2010-1 Page 2 of 2

completion.

-Manufacturer failed to provide a satisfactory Corrective Action Plan for the nonconformities.

-Manufacturer has unpaid invoices.

Effective date of change ( yyyy-mm-dd):

2017-05-23

1 Use the CA reference, if it is known. If it is not known, identify the Member State. The CA reference takes the form XX/CA/YY. XX is the EU abbreviation for the country and YY is the numerical identification of the CA, usually 01

2 The Status Date is the date that the notification is communicated to Member States

3 If there are a large number of devices covered by the certificate, the device names should be attached to this form

4 A detailed explanation is to be given in the ‘Reason for Decision/Comments’ section, for Status Comments marked with a ‘++’

symbols. On occasion, the NB may decide that a reduction certificate scope is necessary. In this case, the Status Code

‘withdrawn’ should be selected along with the Status Comment ‘16 NB reduces certificate scope++’

In accordance with the DA handbook, the DA may consider requiring certificate withdrawals and/or suspensions as a corrective action to notified body nonconformities where:

 there is a high potential danger of certificates of conformity being inappropriately issued and affected product being placed on the market.

The notified body should consider requiring certificate suspension, withdrawal or restriction in cases when, for example In accordance with EN ISO/IEC 17021,

 the legal manufacturer's quality management system has persistently or seriously failed to meet requirements

 the legal manufacturer does not allow surveillance or recertification audits or

 the certified client has voluntarily requested a suspension or in accordance with EN 45011,

 in the event of changes significantly affecting the product’s design or specification

 changes in the standards to which compliance of the product is certified

 changes in the ownership, structure or management of the supplier or

 in the case of information indicating that the product may no longer comply with the requirements of the certification system.

Références

Documents relatifs

This is a retrospective study where patients visiting urology outpatient clinic between January 2016 until May 2018 and treated with the implantation of the Virtue male sling

Multicenter randomized controlled trial of bacterial interference for prevention of urinary tract infection in patients with neurogenic bladder.. Urology

Il s’agit d’une étude prospective descriptive d’une série de cas réalisés sur une période de 3 ans (janvier 2011 à décembre 2013), incluant des patients présentant des

Avec le développement de nouvelles lignes aériennes, les clients disposent d’un plus grand choix de destination de départ dans chaque aéroport.. Cette notion du choix

The implants resulting form precipitating polymer solutions were generally stiffer than those obtained with aqueous-based implants (hydrogels, chitosan, latex, microsphere

1 Urogynecology and Pelvic Floor Unit, Department of Gynecology, Hospital Universitari Vall d'Hebron, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de

is a Cochrane systematic review of pelvic floor muscle training (PFMT) versus no treatment, or inactive control treatments, for urinary incontinence in women (13).. The search for

In this survey of 404 women across the United Arab Emirates, 99 had self-reported stress urinary incontinence and 51% of these stated they would undergo surgery.. This preference